+ Watch FLML
on My Watchlist
A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.
I've had success betting on Flamel several times before, despite my difficulty understanding their platform and collaborations. I'm seeing the share price dip to almost two year lows despite what appears to be increasing licensing revenue so I'm back on the green thumb.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions